Citations (251)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (35)
Dylan A. Hendy, Alex Haven, Eric M. Bachelder & Kristy M. Ainslie. (2023) Preclinical developments in the delivery of protein antigens for vaccination. Expert Opinion on Drug Delivery 20:3, pages 367-384.
Read now
Read now
Yang Lu & Ge Liu. (2022) Nano alum: A new solution to the new challenge. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Chengkai Zhou, Zhuojia Xu, Gen Li, Qi Gao, Qiang Sui & Tiehai Li. (2021) Efficient synthesis of monophosphoryl lipid A mimetic RC-529. Journal of Carbohydrate Chemistry 40:7-9, pages 501-517.
Read now
Read now
G. G. Guerrero Manriquez & I. Tuero. (2021) Adjuvants: friends in vaccine formulations against infectious diseases. Human Vaccines & Immunotherapeutics 17:10, pages 3539-3550.
Read now
Read now
Rui Yu, Yaping Mai, Yue Zhao, Yanhui Hou, Yanhua Liu & Jianhong Yang. (2019) Targeting strategies of liposomal subunit vaccine delivery systems to improve vaccine efficacy. Journal of Drug Targeting 27:7, pages 780-789.
Read now
Read now
Nicolas Lecrenier, Pierre Beukelaers, Romulo Colindres, Desmond Curran, Carine De Kesel, Jean-Philippe De Saegher, Arnaud M Didierlaurent, Edouard Y Ledent, Johann F Mols, Tomas Mrkvan, Marie Normand-Bayle, Lidia Oostvogels, Fernanda Tavares Da Silva, Ventzislav Vassilev, Carlota Vinals & Alain Brecx. (2018) Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention. Expert Review of Vaccines 17:7, pages 619-634.
Read now
Read now
Tino F. Schwarz, Stephanie Volpe, Gregory Catteau, Roman Chlibek, Marie Pierre David, Jan Hendrik Richardus, Himal Lal, Lidia Oostvogels, Karlis Pauksens, Stephanie Ravault, Lars Rombo, Gerard Sonder, Jan Smetana, Thomas Heineman & Adriana Bastidas. (2018) Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults. Human Vaccines & Immunotherapeutics 14:6, pages 1370-1377.
Read now
Read now
Philippe Moris, Erik Jongert & Robbert G. van der Most. (2018) Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine. Human Vaccines & Immunotherapeutics 14:1, pages 17-27.
Read now
Read now
Ruonan Bo, Yaqin Sun, Shuzhen Zhou, Ning Ou, Pengfei Gu, Zhenguang Liu, Yuanliang Hu, Jiaguo Liu & Deyun Wang. (2017) Simple nanoliposomes encapsulating Lycium barbarum polysaccharides as adjuvants improve humoral and cellular immunity in mice. International Journal of Nanomedicine 12, pages 6289-6301.
Read now
Read now
Yahua Lin, Xin Wang, Xiaofen Huang, Jun Zhang, Ningshao Xia & Qinjian Zhao. (2017) Calcium phosphate nanoparticles as a new generation vaccine adjuvant. Expert Review of Vaccines 16:9, pages 895-906.
Read now
Read now
Anthony L. Cunningham & Thomas Heineman. (2017) Vaccine profile of herpes zoster (HZ/su) subunit vaccine. Expert Review of Vaccines 16:7, pages 661-670.
Read now
Read now
Olivier Godeaux, Martina Kovac, Daniel Shu, Katrijn Grupping, Laura Campora, Martine Douha, Thomas C. Heineman & Himal Lal. (2017) Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial. Human Vaccines & Immunotherapeutics 13:5, pages 1051-1058.
Read now
Read now
Peter Vink, Masanari Shiramoto, Masayuki Ogawa, Masahiro Eda, Martine Douha, Thomas Heineman & Himal Lal. (2017) Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly. Human Vaccines & Immunotherapeutics 13:3, pages 574-578.
Read now
Read now
Nathalie Garçon & Alberta Di Pasquale. (2017) From discovery to licensure, the Adjuvant System story. Human Vaccines & Immunotherapeutics 13:1, pages 19-33.
Read now
Read now
Arnaud M. Didierlaurent, Béatrice Laupèze, Alberta Di Pasquale, Nadia Hergli, Catherine Collignon & Nathalie Garçon. (2017) Adjuvant system AS01: helping to overcome the challenges of modern vaccines. Expert Review of Vaccines 16:1, pages 55-63.
Read now
Read now
Michel Fochesato, Najoua Dendouga & Mathieu Boxus. (2016) Comparative preclinical evaluation of AS01 versus other Adjuvant Systems in a candidate herpes zoster glycoprotein E subunit vaccine . Human Vaccines & Immunotherapeutics 12:8, pages 2092-2095.
Read now
Read now
Carl R. Alving, Zoltan Beck, Gary R. Matyas & Mangala Rao. (2016) Liposomal adjuvants for human vaccines. Expert Opinion on Drug Delivery 13:6, pages 807-816.
Read now
Read now
Adebayo J. Molehin, Juan U. Rojo, Sabrina Z. Siddiqui, Sean A. Gray, Darrick Carter & Afzal A. Siddiqui. (2016) Development of a schistosomiasis vaccine. Expert Review of Vaccines 15:5, pages 619-627.
Read now
Read now
Masaud Shah, Muhammad Ayaz Anwar, Jae-Ho Kim & Sangdun Choi. (2016) Advances in Antiviral Therapies Targeting Toll-like Receptors. Expert Opinion on Investigational Drugs 25:4, pages 437-453.
Read now
Read now
Anthony L. Cunningham. (2016) The herpes zoster subunit vaccine. Expert Opinion on Biological Therapy 16:2, pages 265-271.
Read now
Read now
Jing Hu, Liying Qiu, Xiaoli Wang, Xiaopeng Zou, Mengji Lu & Jian Yin. (2015) Carbohydrate-based vaccine adjuvants – discovery and development. Expert Opinion on Drug Discovery 10:10, pages 1133-1144.
Read now
Read now
Melissa Santone, Susanna Aprea, Tom Y H Wu, Michael P Cooke, M Lamine Mbow, Nicholas M Valiante, James S Rush, Stephanie Dougan, Ana Avalos, Hidde Ploegh, Ennio De Gregorio, Cecilia Buonsanti & Ugo D'Oro. (2015) A new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cells. Human Vaccines & Immunotherapeutics 11:8, pages 2038-2050.
Read now
Read now
Afshin Zariri & Peter van der Ley. (2015) Biosynthetically engineered lipopolysaccharide as vaccine adjuvant. Expert Review of Vaccines 14:6, pages 861-876.
Read now
Read now
Abid H. Banday, Salika Jeelani & Victor J. Hruby. (2015) Cancer vaccine adjuvants – recent clinical progress and future perspectives. Immunopharmacology and Immunotoxicology 37:1, pages 1-11.
Read now
Read now
Tessa Moses, Kalliope K. Papadopoulou & Anne Osbourn. (2014) Metabolic and functional diversity of saponins, biosynthetic intermediates and semi-synthetic derivatives. Critical Reviews in Biochemistry and Molecular Biology 49:6, pages 439-462.
Read now
Read now
Geert Leroux-Roels, Isabel Leroux-Roels, Frédéric Clement, Opokua Ofori-Anyinam, Marc Lievens, Erik Jongert, Philippe Moris, W Ripley Ballou & Joe Cohen. (2014) Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines. Human Vaccines & Immunotherapeutics 10:8, pages 2211-2219.
Read now
Read now
Elham Mohit, Atieh Hashemi & Mojgan Allahyari. (2014) Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines. Expert Review of Clinical Immunology 10:7, pages 927-961.
Read now
Read now
Himal Lal, Toufik Zahaf & Thomas Heineman. (2013) Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su). Human Vaccines & Immunotherapeutics 9:7, pages 1425-1429.
Read now
Read now
Christopher B Fox & Jean Haensler. (2013) An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. Expert Review of Vaccines 12:7, pages 747-758.
Read now
Read now
Jessica C. Dong & Gary P. Kobinger. (2013) Hypothesis driven development of new adjuvants. Human Vaccines & Immunotherapeutics 9:4, pages 808-811.
Read now
Read now
Swapan K Ghosh & Roshni Roy Chowdhury. (2013) Synthetic adjuvants for vaccine formulations: phytol derivatives. Expert Opinion on Drug Delivery 10:4, pages 437-450.
Read now
Read now
Aiala Salvador, Rosa M Hernández, José Luis Pedraz & Manoli Igartua. (2012) Plasmodium falciparum malaria vaccines: current status, pitfalls and future directions. Expert Review of Vaccines 11:9, pages 1071-1086.
Read now
Read now
Carl R Alving, Mangala Rao, Nicholas J Steers, Gary R Matyas & Alexander V Mayorov. (2012) Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines. Expert Review of Vaccines 11:6, pages 733-744.
Read now
Read now
Colleen Olive. (2012) Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants. Expert Review of Vaccines 11:2, pages 237-256.
Read now
Read now
Joseph U Igietseme, Francis O Eko & Carolyn M Black. (2011) Chlamydia vaccines: recent developments and the role of adjuvants in future formulations. Expert Review of Vaccines 10:11, pages 1585-1596.
Read now
Read now
Articles from other publishers (216)
Sandeep Dinday & Sumit Ghosh. (2023) Recent advances in triterpenoid pathway elucidation and engineering. Biotechnology Advances 68, pages 108214.
Crossref
Crossref
Simon Doss-Gollin, Sanya Thomas, Byron Brook, Kimia Abedi, Célia Lebas, Floriane Auderset, Yamile Lugo-Rodriguez, Guzman Sanchez-Schmitz, David J. Dowling, Ofer Levy & Simon D. van Haren. (2023) Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen. npj Vaccines 8:1.
Crossref
Crossref
Zvavahera Mike Chirenje, Fatima Laher, One Dintwe, Monde Muyoyeta, Allan C deCamp, Zonglin He, Nicole Grunenberg, Faatima Laher Omar, Kelly E Seaton, Laura Polakowski, Amanda S Woodward Davis, Lucas Maganga, Lindsey R Baden, Kenneth Mayer, Spyros Kalams, Michael Keefer, Srilatha Edupuganti, Benigno Rodriguez, Ian Frank, Hyman Scott, Lynda Stranix-Chibanda, Sanjay Gurunathan, Marguerite Koutsoukos, Olivier Van Der Meeren, Carlos A DiazGranados, Carmen Paez, Erica Andersen-Nissen, James Kublin, Lawrence Corey, Guido Ferrari, Georgia Tomaras & M Juliana McElrath. (2023) Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120. The Journal of Infectious Diseases.
Crossref
Crossref
Zhen Li, Isra Rana, Gyungdeuk Park, Jinwoo Lee, Chae Eun Park & Jutaek Nam. (2023) Pattern recognition receptors and their nano-adjuvants for cancer immunotherapy. Journal of Pharmaceutical Investigation.
Crossref
Crossref
Gang Hu, David J. Varisco, Sayan Das, C. Russell Middaugh, Francesca Gardner, Robert K. Ernst, Wendy L. Picking & William D. Picking. (2023) Physicochemical characterization of biological and synthetic forms of two lipid A-based TLR4 agonists. Heliyon 9:7, pages e18119.
Crossref
Crossref
Jerry Yan, Ben S. Ou, Olivia M. Saouaf, Emily L. Meany, Noah Eckman & Eric A. Appel. (2023) A Regimen Compression Strategy for Commercial Vaccines Leveraging an Injectable Hydrogel Depot Technology for Sustained Vaccine Exposure. Advanced Therapeutics.
Crossref
Crossref
Mikhail A. Nazarov, Irina A. Tolmacheva, Olga N. Gagarskih & Victoria V. Grishko. (2022) Synthesis and cytotoxic activity of triterpenoids with N,O-heterocyclic fragments based on 2-formyl-1(2)-ene derivative of methyldihydrobetulonate. Chemical Papers 77:4, pages 2219-2227.
Crossref
Crossref
Isabel Leroux-Roels, Matthew G Davis, Katie Steenackers, Brandon Essink, Corinne Vandermeulen, Charles Fogarty, Charles P Andrews, Edward Kerwin, Marie-Pierre David, Laurence Fissette, Carline Vanden Abeele, Delphine Collete, Magali de Heusch, Bruno Salaun, Nathalie De Schrevel, Juliane Koch, Céline Verheust, Nancy Dezutter, Frank Struyf, Narcisa Mesaros, Jelena Tica & Veronica Hulstrøm. (2023) Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial. The Journal of Infectious Diseases 227:6, pages 761-772.
Crossref
Crossref
Kai Chen, Ning Wang, Xiaomin Zhang, Meng Wang, Yanyu Liu & Yun Shi. (2023) Potentials of saponins-based adjuvants for nasal vaccines. Frontiers in Immunology 14.
Crossref
Crossref
Karolina D. Witt. (2023) Role of MHC class I pathways in Mycobacterium tuberculosis antigen presentation. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Xiyue He, Xiaoyan Chen, Hairui Wang, Guangsheng Du & Xun Sun. (2023) Recent advances in respiratory immunization: A focus on COVID-19 vaccines. Journal of Controlled Release 355, pages 655-674.
Crossref
Crossref
Shailendra Kumar Verma, Pooja Mahajan, Nikhlesh K. Singh, Ankit Gupta, Rupesh Aggarwal, Rino Rappuoli & Atul Kumar Johri. (2023) New-age vaccine adjuvants, their development, and future perspective. Frontiers in Immunology 14.
Crossref
Crossref
Dong-Ha Lee, Eun-bee Lee, Jong-pil Seo & Eun-Ju Ko. (2023)
In vitro
effects of monophosphoryl lipid A and Poly I:C combination on equine cells
. Journal of Veterinary Science 24:3.
Crossref
Crossref
Myron J. Levin. 2023. Plotkin's Vaccines. Plotkin's Vaccines
1334
1349.e7
.
Hemanga Hazarika, Harshita Krishnatreyya, Bedanta Bhattacharjee, Damanbhalang Rynjah, Dharmajit Gogoi, Abdul Baquee Ahmed & Kamaruz Zaman. 2023. Malarial Drug Delivery Systems. Malarial Drug Delivery Systems
161
185
.
Junli Li, Lili Fu, Xiaonan Guo, Yang Yang, Jiaxin Dong, Guozhi Wang & Aihua Zhao. (2022) Novel BC02 Compound Adjuvant Enhances Adaptive and Innate Immunity Induced by Recombinant Glycoprotein E of Varicella-Zoster Virus. Vaccines 10:12, pages 2155.
Crossref
Crossref
Hyunjung Kim, Jigui Yu, Di Bai, Moon H. Nahm & Pengfei Wang. (2022) Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1. Frontiers in Immunology 13.
Crossref
Crossref
Patrick Syntin, Fabienne Piras-Douce, François Dalençon, Marie Garinot & Jean Haensler. (2022) Nonclinical safety assessments of a novel synthetic toll-like receptor 4 agonist and saponin based adjuvant. Toxicology and Applied Pharmacology, pages 116358.
Crossref
Crossref
Kang Liang, Zhenyuan Tian, Xin Chen, Mengru Li, Xiaofen Zhang, Xiaoping Bian, Md Kaisar Ali & Qingke Kong. (2022) Attenuated Salmonella Typhimurium with truncated LPS and outer membrane-displayed RGD peptide for cancer therapy. Biomedicine & Pharmacotherapy 155, pages 113682.
Crossref
Crossref
Sachin S. Shivatare, Vidya S. Shivatare & Chi-Huey Wong. (2022) Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments. Chemical Reviews 122:20, pages 15603-15671.
Crossref
Crossref
Jake S. O’Donnell, Ariel Isaacs, Virginie Jakob, Celia Lebas, James B. Barnes, Patrick C. Reading, Paul R. Young, Daniel Watterson, Patrice M. Dubois, Nicolas Collin & Keith J. Chappell. (2022) Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine. Frontiers in Immunology 13.
Crossref
Crossref
Linyu Wu, Xiaohui Xian, Guangyu Xu, Zixuan Tan, Fang Dong, Min Zhang & Feng Zhang. (2022) Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer’s Disease. Mediators of Inflammation 2022, pages 1-20.
Crossref
Crossref
Hongmin Kim & Sung Jae Shin. (2022) Pathological and protective roles of dendritic cells in Mycobacterium tuberculosis infection: Interaction between host immune responses and pathogen evasion. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Teerasit Techawiwattanaboon, Thomas Courant, Livia Brunner, Suwitra Sathean-anan-kun, Pratomporn Krangvichian, Nutta Iadsee, Yaowarin Nakornpakdee, Noppadon Sangjun, Pat Komanee, Nicolas Collin, Kiat Ruxrungtham & Kanitha Patarakul. (2022) Designing Adjuvant Formulations to Promote Immunogenicity and Protective Efficacy of Leptospira Immunoglobulin-Like Protein A Subunit Vaccine. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Alessio Facciolà, Giuseppa Visalli, Antonio Laganà & Angela Di Pietro. (2022) An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives. Vaccines 10:5, pages 819.
Crossref
Crossref
Barry T. Rouse & D. Scott Schmid. (2022) Fraternal Twins: The Enigmatic Role of the Immune System in Alphaherpesvirus Pathogenesis and Latency and Its Impacts on Vaccine Efficacy. Viruses 14:5, pages 862.
Crossref
Crossref
Xiuran Wang, Peng Li, Amit K. Singh, Xiangmin Zhang, Ziqiang Guan, Roy CurtissIIIIII & Wei Sun. (2022)
Remodeling
Yersinia pseudotuberculosis
to generate a highly immunogenic outer membrane vesicle vaccine against pneumonic plague
. Proceedings of the National Academy of Sciences 119:11.
Crossref
Crossref
Sasha E. Larsen, Brittany D. Williams, Maham Rais, Rhea N. Coler & Susan L. Baldwin. (2022) It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity. Frontiers in Immunology 13.
Crossref
Crossref
Lívia Mendes Carvalho, Miriã Rodrigues Gusmão, Ana Flávia Pereira Costa, Rory Cristiane Fortes de Brito, Rodrigo Dian de Oliveira Aguiar-Soares, Jamille Mirelle de Oliveira Cardoso, Alexandre Barbosa Reis, Cláudia Martins Carneiro & Bruno Mendes Roatt. (2021) Immunochemotherapy for visceral leishmaniasis: combinatorial action of Miltefosine plus LBSapMPL vaccine improves adaptative Th1 immune response with control of splenic parasitism in experimental hamster model. Parasitology 149:3, pages 371-379.
Crossref
Crossref
Jing-Xing Yang, Jen-Chih Tseng, Guann-Yi Yu, Yunping Luo, Chi-Ying F. Huang, Yi-Ren Hong & Tsung-Hsien Chuang. (2022) Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases. Pharmaceutics 14:2, pages 423.
Crossref
Crossref
Pilar Garcia-Vello, Flaviana Di Lorenzo, Daniele Zucchetta, Alla Zamyatina, Cristina De Castro & Antonio Molinaro. (2022) Lipopolysaccharide lipid A: A promising molecule for new immunity-based therapies and antibiotics. Pharmacology & Therapeutics 230, pages 107970.
Crossref
Crossref
Dharmendra Kumar Khatri, Jitender Madan, Kiran Jyoti & Shashi Bala Singh. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers
347
377
.
Jenci Hawthorne, Haval Shirwan & Esma Yolcu. 2022. Cancer Vaccines as Immunotherapy of Cancer. Cancer Vaccines as Immunotherapy of Cancer
209
226
.
Rushit N. Lodaya, Sonia Gregory, Mansoor M. Amiji & Derek T. O'Hagan. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development
9
25
.
Birgit Weinberger. 2022. Healthy Longevity and Immune System. Healthy Longevity and Immune System
119
164
.
Farrhana Ziana Firdaus, Mariusz Skwarczynski & Istvan Toth. 2022. Vaccine Design. Vaccine Design
145
178
.
Birgit Weinberger. (2021) Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond. Immunity & Ageing 18:1.
Crossref
Crossref
Hualin Li, Morgan A. Monslow, Daniel C. Freed, Dan Chang, Fengsheng Li, Marian Gindy, Dai Wang, Kalpit Vora, Amy S. Espeseth, Nikolai Petrovsky & Tong-Ming Fu. (2021) Novel adjuvants enhance immune responses elicited by a replication-defective human cytomegalovirus vaccine in nonhuman primates. Vaccine 39:51, pages 7446-7456.
Crossref
Crossref
Guang Han Ong, Benedict Shi Xiang Lian, Takumi Kawasaki & Taro Kawai. (2021) Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Patrick B. Memvanga & Christian I. Nkanga. (2021) Liposomes for malaria management: the evolution from 1980 to 2020. Malaria Journal 20:1.
Crossref
Crossref
Nikunj Tandel & Sarat K. Dalai. 2021. Current Topics and Emerging Issues in Malaria Elimination. Current Topics and Emerging Issues in Malaria Elimination.
Adam M. Sandor, Michael S. Sturdivant & Jenny P. Y. Ting. (2021) Influenza Virus and SARS-CoV-2 Vaccines. The Journal of Immunology 206:11, pages 2509-2520.
Crossref
Crossref
Susanna Esposito, Giulia Chiopris, Giulia Messina, Tiziana D’Alvano, Serafina Perrone & Nicola Principi. (2021) Prevention of Congenital Cytomegalovirus Infection with Vaccines: State of the Art. Vaccines 9:5, pages 523.
Crossref
Crossref
Joseph R. Francica, Wei Shi, Gwo-Yu Chuang, Steven J. Chen, Lais Da Silva Pereira, S. Katie Farney, Barbara J. Flynn, Li Ou, Tyler Stephens, Yaroslav Tsybovsky, Lawrence T. Wang, Alexander Anderson, Zoltan Beck, Marlon Dillon, Azza H. Idris, Nicholas Hurlburt, Tracy Liu, Baoshan Zhang, Carl R. Alving, Gary R. Matyas, Marie Pancera, John R. Mascola, Peter D. Kwong & Robert A. Seder. (2021) Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against Malaria. Vaccines 9:3, pages 272.
Crossref
Crossref
Pengfei Wang. (2021) Natural and Synthetic Saponins as Vaccine Adjuvants. Vaccines 9:3, pages 222.
Crossref
Crossref
Alan H. Stokes, Kelle Franklin, Daniel E. Fisher, Lorraine M. Posobiec, Ornella Binazon, Niraj Tripathi, Michael Alan Ringenberg, Jeffrey Charlap, Mary K. Ziejewski, Vimala Vemireddi, Payal Khanna Weiss, Ritankar Majumdar, Badiaa Bouzya, Marie-Noëlle Donner, Luis-Alexander Rodriguez & Judith Baumeister. (2021) Repeated Dose Toxicity Study and Developmental and Reproductive Toxicology Studies of a Respiratory Syncytial Virus Candidate Vaccine in Rabbits and Rats. International Journal of Toxicology 40:2, pages 125-142.
Crossref
Crossref
Zhi-Yong Zeng, Jin-Xi Liao, Zhen-Ni Hu, De-Yong Liu, Qing-Ju Zhang & Jian-Song Sun. (2021) Chemical synthesis of quillaic acid, the aglycone of QS-21. Organic Chemistry Frontiers 8:4, pages 748-753.
Crossref
Crossref
Anthony L Cunningham, Peter McIntyre, Kanta Subbarao, Robert Booy & Myron J Levin. (2021) Vaccines for older adults. BMJ, pages n188.
Crossref
Crossref
Carlo Pifferi, Roberto Fuentes & Alberto Fernández-Tejada. (2021) Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action. Nature Reviews Chemistry 5:3, pages 197-216.
Crossref
Crossref
Zhuofan Li, Yiwen Zhao, Yibo Li & Xinyuan Chen. (2021) Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity. Vaccines 9:2, pages 75.
Crossref
Crossref
Cedric Bosteels, Kaat Fierens, Sofie De Prijck, Justine Van Moorleghem, Manon Vanheerswynghels, Caroline De Wolf, Aurélie Chalon, Catherine Collignon, Hamida Hammad, Arnaud M. Didierlaurent & Bart N. Lambrecht. (2021) CCR2- and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01. Frontiers in Immunology 11.
Crossref
Crossref
Ankita H. Tripathi, Priyanka H. Tripathi & Anupam Pandey. 2021. Pathogenesis, Treatment and Prevention of Leishmaniasis. Pathogenesis, Treatment and Prevention of Leishmaniasis
161
182
.
Carla Delporte, Maité Rodríguez-Díaz & Bruce K. Cassels. 2021. Medicinal and Aromatic Plants of South America Vol. 2. Medicinal and Aromatic Plants of South America Vol. 2
461
473
.
Myron J. Levin & Adriana Weinberg. 2023. Varicella-zoster Virus. Varicella-zoster Virus
223
246
.
Zhi-Yong Zeng, Jin-Xi Liao, Zhen-Ni Hu, De-Yong Liu, Qing-Ju Zhang & Jian-Song Sun. (2020) Synthetic Investigation toward QS-21 Analogues. Organic Letters 22:21, pages 8613-8617.
Crossref
Crossref
Yu Zheng, Lijun Bian, Huiting Zhao, Yulan Liu, Jingcai Lu, Dawei Liu, Ke Zhang, Yueshuang Song, Yusi Luo, Chunlai Jiang, Yan Chen, Yong Zhang & Wei Kong. (2020) Respiratory Syncytial Virus F Subunit Vaccine With AS02 Adjuvant Elicits Balanced, Robust Humoral and Cellular Immunity in BALB/c Mice. Frontiers in Immunology 11.
Crossref
Crossref
Thomas J. Scriba, Mihai G. Netea & Ann M. Ginsberg. (2020) Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis. Seminars in Immunology 50, pages 101431.
Crossref
Crossref
Zixuan Cai, Ting Ye, Xing Xu, Minhui Gao, Yaru Zhang, Dan Wang, Yiming Gu, Haojie Zhu, Lijuan Tong, Jiashu Lu, Zhuo Chen & Chao Huang. (2020) Antidepressive properties of microglial stimulation in a mouse model of depression induced by chronic unpredictable stress. Progress in Neuro-Psychopharmacology and Biological Psychiatry 101, pages 109931.
Crossref
Crossref
Fumi Sato-Kaneko, Shiyin Yao, Fitzgerald S. Lao, Jonathan Shpigelman, Karen Messer, Minya Pu, Nikunj M. Shukla, Howard B. Cottam, Michael Chan, Paul J. Chu, David Burkhart, Roman Schoener, Takaji Matsutani, Dennis A. Carson, Maripat Corr & Tomoko Hayashi. (2020) A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity. Frontiers in Immunology 11.
Crossref
Crossref
Josilene Ramos Pinheiro-Michelsen, Rayane da Silva Oliveira Souza, Itana Vivian Rocha Santana, Patrícia de Souza da Silva, Erick Carvalho Mendez, Wilson Barros Luiz & Jaime Henrique Amorim. (2020) Anti-dengue Vaccines: From Development to Clinical Trials. Frontiers in Immunology 11.
Crossref
Crossref
Yaghob Azadi, Ehsan Ahmadpour & Amirhossein Ahmadi. (2020) Targeting Strategies in Therapeutic Applications of Toxoplasmosis: Recent Advances in Liposomal Vaccine Delivery Systems. Current Drug Targets 21:6, pages 541-558.
Crossref
Crossref
Angelika Wagner & Birgit Weinberger. (2020) Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives. Frontiers in Immunology 11.
Crossref
Crossref
Leopoldo F.M. Nascimento, Dayane Francisca Higino Miranda, Luana D. Moura, Flaviane A. Pinho, Guilherme Loureiro Werneck, Ricardo Khouri, Steven G. Reed, Malcolm S. Duthie, Aldina Barral, Manoel Barral-Netto & Maria S.P. Cruz. (2020) Allopurinol therapy provides long term clinical improvement, but additional immunotherapy is required for sustained parasite clearance, in L. infantum-infected dogs. Vaccine: X 4, pages 100048.
Crossref
Crossref
Jinyong Zhang, Hao Zeng, Jiang Gu, Haibo Li, Lixin Zheng & Quanming Zou. (2020) Progress and Prospects on Vaccine Development against SARS-CoV-2. Vaccines 8:2, pages 153.
Crossref
Crossref
Laurent Derré, Ilaria Lucca, Valérie Cesson, Massimo Valerio, Yannick Cerantola, Rodolfo Burruni, Urs Fritschi, Dalila Gharbi, Martine Bobst, Anne-Sophie Legris, Florence Dartiguenave, Patrice Jichlinski & Denise Nardelli-Haefliger. (2020) Intramuscular Immunization Induces Antigen-specific Antibodies in Urine. European Urology Focus 6:2, pages 280-283.
Crossref
Crossref
Barry R Bloom. (2020) The search for better vaccines against TB. BMJ, pages m92.
Crossref
Crossref
Sandeep & Sumit Ghosh. 2020. Bioactive Natural Products. Bioactive Natural Products
411
461
.
Kristopher K. Short, Shannon M. Miller, Lois Walsh, Van Cybulski, Hélène Bazin, Jay T. Evans & David Burkhart. (2019) Co-encapsulation of synthetic lipidated TLR4 and TLR7/8 agonists in the liposomal bilayer results in a rapid, synergistic enhancement of vaccine-mediated humoral immunity. Journal of Controlled Release 315, pages 186-196.
Crossref
Crossref
Samaneh H. Shabani, Sedigheh Zakeri, Yousef Mortazavi & Akram A. Mehrizi. (2019) Immunological evaluation of two novel engineered Plasmodium vivax circumsporozoite proteins formulated with different human-compatible vaccine adjuvants in C57BL/6 mice. Medical Microbiology and Immunology 208:6, pages 731-745.
Crossref
Crossref
Margarida Correia-Neves, Christopher Sundling, Andrea Cooper & Gunilla Källenius. (2019) Lipoarabinomannan in Active and Passive Protection Against Tuberculosis. Frontiers in Immunology 10.
Crossref
Crossref
Zhenhua Ji, Miaomiao Jian, Taigui Chen, Lisha Luo, Lianbao Li, Xiting Dai, Ruolan Bai, Zhe Ding, Yunfeng Bi, Shiyuan Wen, Guozhong Zhou, Manzama-Esso Abi, Aihua Liu & Fukai Bao. (2019) Immunogenicity and Safety of the M72/AS01E Candidate Vaccine Against Tuberculosis: A Meta-Analysis. Frontiers in Immunology 10.
Crossref
Crossref
Pengfei Wang, Đani Škalamera, Xianwei Sui, Ping Zhang & Suzanne M. Michalek. (2019) Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants. ACS Infectious Diseases 5:6, pages 974-981.
Crossref
Crossref
Yve VS Magedans, Anna CA Yendo, Fernanda de Costa, Grace Gosmann & Arthur G Fett-Neto. (2019)
Foamy matters: an update on
Quillaja
saponins and their use as immunoadjuvants
. Future Medicinal Chemistry 11:12, pages 1485-1499.
Crossref
Crossref
Hussein Masoud. (2019) Novel adjuvants derived from attenuated lipopolysaccharides and lipid As of purple non-sulfur photosynthetic bacteria. Vaccine 37:26, pages 3472-3477.
Crossref
Crossref
Emiliano Manzo, Carmela Gallo, Laura Fioretto, Genoveffa Nuzzo, Giusi Barra, Dario Pagano, Irene Russo Krauss, Luigi Paduano, Marcello Ziaco, Marina DellaGreca, Raffaele De Palma & Angelo Fontana. (2019) Diasteroselective Colloidal Self-Assembly Affects the Immunological Response of the Molecular Adjuvant Sulfavant. ACS Omega 4:4, pages 7807-7814.
Crossref
Crossref
Pengfei Wang, Đani Škalamera, Xianwei Sui, Ping Zhang & Suzanne M. Michalek. (2019) Synthesis and Evaluation of a QS-17/18-Based Vaccine Adjuvant. Journal of Medicinal Chemistry 62:3, pages 1669-1676.
Crossref
Crossref
Anthony L. Cunningham, Myron J. Levin & Thomas C. Heineman. 2019. Vaccinations. Vaccinations
55
73
.
Mahsa Keshavarz-Fathi & Nima Rezaei. 2019. Vaccines for Cancer Immunotherapy. Vaccines for Cancer Immunotherapy
45
59
.
Anna-Mari Reid & Namrita Lall. 2019. Medicinal Plants. Medicinal Plants
187
213
.
Nataschja I. Ho, Lisa G. M. Huis in 't Veld, Tonke K. Raaijmakers & Gosse J. Adema. (2018) Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?. Frontiers in Immunology 9.
Crossref
Crossref
Stina Hellman, Bernt Hjertner, Bror Morein & Caroline Fossum. (2018) The adjuvant G3 promotes a Th1 polarizing innate immune response in equine PBMC. Veterinary Research 49:1.
Crossref
Crossref
Sumera Y. Younis, Christophe Barnier-Quer, Simon Heuking, Vinod Sommandas, Livia Brunner, Nicole vd.Werff, Patrice Dubois, Martin Friede, Clemens Kocken, Nicolas Collin & Ed Remarque. (2018) Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation. BMC Immunology 19:1.
Crossref
Crossref
Cheryl Lai-Lai Chiang & Lana E. Kandalaft. (2018) In vivo cancer vaccination: Which dendritic cells to target and how?. Cancer Treatment Reviews 71, pages 88-101.
Crossref
Crossref
Ali M. Harandi. (2018) Systems analysis of human vaccine adjuvants. Seminars in Immunology 39, pages 30-34.
Crossref
Crossref
Giuseppe Del Giudice, Rino Rappuoli & Arnaud M. Didierlaurent. (2018) Correlates of adjuvanticity: A review on adjuvants in licensed vaccines. Seminars in Immunology 39, pages 14-21.
Crossref
Crossref
Anthony L Cunningham & Myron J Levin. (2018) Herpes Zoster Vaccines. The Journal of Infectious Diseases 218:suppl_2, pages S127-S133.
Crossref
Crossref
Shakti Singh, Eric G. Ramírez-Salazar, Rami Doueiri, Antonio Valentin, Margherita Rosati, Xintao Hu, Brandon F. Keele, Xiaoying Shen, Georgia D. Tomaras, Guido Ferrari, Celia LaBranche, David C. Montefiori, Jishnu Das, Galit Alter, Hung V. Trinh, Christopher Hamlin, Mangala Rao, Frances Dayton, Jenifer Bear, Bhabadeb Chowdhury, Candido Alicea, Jeffrey D. Lifson, Kate E. Broderick, Niranjan Y. Sardesai, Sandra J. Sivananthan, Christopher B. Fox, Steven G. Reed, David J. Venzon, Vanessa M. Hirsch, George N. Pavlakis & Barbara K. Felber. (2018)
Control of Heterologous Simian Immunodeficiency Virus SIV
smE660
Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques
. Journal of Virology 92:15.
Crossref
Crossref
Marc Baay, Kaatje Bollaerts & Thomas Verstraeten. (2018) A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adults. Vaccine 36:29, pages 4207-4214.
Crossref
Crossref
Zoltan Beck, Oscar B. Torres, Gary R. Matyas, David E. Lanar & Carl R. Alving. (2018) Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex. Journal of Controlled Release 275, pages 12-19.
Crossref
Crossref
Robert A. van den Berg, Laurane De Mot, Geert Leroux-Roels, Viviane Bechtold, Frédéric Clement, Margherita Coccia, Erik Jongert, Thomas G. Evans, Paul Gillard & Robbert G. van der Most. (2018) Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette–Guérin-Vaccinated Adults. Frontiers in Immunology 9.
Crossref
Crossref
Blaise Corthésy & Gilles Bioley. (2018) Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection. Frontiers in Immunology 9.
Crossref
Crossref
Brendon Y. ChuaToshiki SekiyaDavid C. Jackson. (2018) Opinion: Making Inactivated and Subunit-Based Vaccines Work. Viral Immunology 31:2, pages 150-158.
Crossref
Crossref
Myron J. Levin. 2018. Plotkin's Vaccines. Plotkin's Vaccines
1268
1281.e6
.
Farzad Khademi, Ramezan Ali Taheri, Amir Abbas Momtazi-Borojeni, Gholamreza Farnoosh, Thomas P. Johnston & Amirhossein Sahebkar. 2018. Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175. Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175
47
69
.
Katrijn Grupping, Laura Campora, Martine Douha, Thomas C Heineman, Nicola P Klein, Himal Lal, James Peterson, Ilse Vastiau & Lidia Oostvogels. (2017) Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine. The Journal of Infectious Diseases 216:11, pages 1343-1351.
Crossref
Crossref
Adebayo J. Molehin, Souad R. Sennoune, Weidong Zhang, Juan U. Rojo, Arif J. Siddiqui, Karlie A. Herrera, Laura Johnson, Justin Sudduth, Jordan May & Afzal A. Siddiqui. (2017) Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium. Parasitology Research 116:11, pages 3175-3188.
Crossref
Crossref
Alicja Misiak, Rosanna Leuzzi, Aideen C. Allen, Bruno Galletti, Barbara C. Baudner, Ugo D'Oro, Derek T. O'Hagan, Mariagrazia Pizza, Anja Seubert & Kingston H.G. Mills. (2017) Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model. Vaccine 35:39, pages 5256-5263.
Crossref
Crossref
Srinivasa Reddy Bonam, Charalambos D. Partidos, Sampath Kumar M. Halmuthur & Sylviane Muller. (2017) An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy. Trends in Pharmacological Sciences 38:9, pages 771-793.
Crossref
Crossref
Wivine Burny, Andrea Callegaro, Viviane Bechtold, Frédéric Clement, Sophie Delhaye, Laurence Fissette, Michel Janssens, Geert Leroux-Roels, Arnaud Marchant, Robert A. van den Berg, Nathalie Garçon, Robbert van der Most & Arnaud M. Didierlaurent. (2017) Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans. Frontiers in Immunology 8.
Crossref
Crossref
Derek T O’Hagan, Leonard R Friedland, Emmanuel Hanon & Arnaud M Didierlaurent. (2017) Towards an evidence based approach for the development of adjuvanted vaccines. Current Opinion in Immunology 47, pages 93-102.
Crossref
Crossref
Elizabeth A .Thompson & Karin Loré. (2017) Non-human primates as a model for understanding the mechanism of action of toll-like receptor-based vaccine adjuvants. Current Opinion in Immunology 47, pages 1-7.
Crossref
Crossref
Kelsey A. Gregg, Erin Harberts, Francesca M. Gardner, Mark R. Pelletier, Corinne Cayatte, Li Yu, Michael P. McCarthy, Jason D. Marshall & Robert K. Ernst. (2017) Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery. mBio 8:3.
Crossref
Crossref
Mushtaq Ahmed, Hongmei Jiao, Racquel Domingo-Gonzalez, Shibali Das, Kristin L Griffiths, Javier Rangel-Moreno, Uma M Nagarajan & Shabaana A Khader. (2017)
Rationalized design of a mucosal vaccine protects against
Mycobacterium tuberculosis
challenge in mice
. Journal of Leukocyte Biology 101:6, pages 1373-1381.
Crossref
Crossref
Hyun Ju In, Heeji Lim, Jung-Ah Lee, Hye Jin Kim, Jin-Won Kim, Ji-Yeon Hyeon, Sang-Gu Yeo, June-Woo Lee, Jung Sik Yoo, Young Ki Choi & Sang-Won Lee. (2017) An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice. PLOS ONE 12:5, pages e0178259.
Crossref
Crossref
Robert A. van den Berg, Margherita Coccia, W. Ripley Ballou, Kent E. Kester, Christian F. Ockenhouse, Johan Vekemans, Erik Jongert, Arnaud M. Didierlaurent & Robbert G. van der Most. (2017) Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial. Frontiers in Immunology 8.
Crossref
Crossref
Lawrence Segal, Karen Thacker, Michel Fochesato, Giulia Giordano, Nathalie Garçon & Eric Destexhe. (2017) Intramuscularly administered herpes zoster subunit vaccine has no effects on fertility, pre- and post-natal development in Sprague-Dawley rats. Reproductive Toxicology 69, pages 297-307.
Crossref
Crossref
Giulia Giordano, Lawrence Segal, Menk Prinsen, Marcel V. W. Wijnands, Nathalie Garçon & Eric Destexhe. (2017) Non-clinical safety assessment of single and repeated administration of gE/AS01 zoster vaccine in rabbits. Journal of Applied Toxicology 37:2, pages 132-141.
Crossref
Crossref
K.L. Wilson, S.D. Xiang & M. Plebanski. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development
99
125
.
A.M. Didierlaurent, A. Berger, T.C. Heineman, V. Henderickx, F. Tavares Da Silva, J. Vekemans, G. Voss & N. Garçon. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
265
285
.
Stela Maris Kuze Rates, Andresa Heemann Betti, Liz Girardi Müller & Jéssica de Matos Nunes. 2017. Plant Toxins. Plant Toxins
81
105
.
Ruchi R. Shah, Kimberly J. Hassett & Luis A. Brito. 2017. Vaccine Adjuvants. Vaccine Adjuvants
1
13
.
Sophie Detienne, Iain Welsby, Catherine Collignon, Sandrine Wouters, Margherita Coccia, Sophie Delhaye, Laurye Van Maele, Séverine Thomas, Maëlle Swertvaegher, Aurélie Detavernier, Abdelatif Elouahabi, Stanislas Goriely & Arnaud M. Didierlaurent. (2016) Central Role of CD169+ Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01. Scientific Reports 6:1.
Crossref
Crossref
Fateme Gableh, Mohsen Saeidi, Shaghayegh Hemati, Kasra Hamdi, Hoorieh Soleimanjahi, Ali Gorji & Amir Ghaemi. (2016) Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine. Journal of Biomedical Science 23:1.
Crossref
Crossref
Anthony L. Cunningham, Nathalie Garçon, Oberdan Leo, Leonard R. Friedland, Richard Strugnell, Béatrice Laupèze, Mark Doherty & Peter Stern. (2016) Vaccine development: From concept to early clinical testing. Vaccine 34:52, pages 6655-6664.
Crossref
Crossref
Satoshi Wada, Erika Yada, Junya Ohtake, Yuki Fujimoto, Hidemi Uchiyama, Shintaro Yoshida & Tetsuro Sasada. (2016) Current status and future prospects of peptide-based cancer vaccines. Immunotherapy 8:11, pages 1321-1333.
Crossref
Crossref
Hok Hei Tam, Mariane B. Melo, Myungsun KangJeisa M. PeletVera M. RudaMaria H. FoleyJoyce K. HuSudha KumariJordan CramptonAlexis D. BaldeonRogier W. SandersJohn P. MooreShane CrottyRobert LangerDaniel G. AndersonArup K. ChakrabortyDarrell J. Irvine. (2016) Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination. Proceedings of the National Academy of Sciences 113:43.
Crossref
Crossref
Anthony L. Cunningham, Himal Lal, Martina Kovac, Roman Chlibek, Shinn-Jang Hwang, Javier Díez-Domingo, Olivier Godeaux, Myron J. Levin, Janet E. McElhaney, Joan Puig-Barberà, Carline Vanden Abeele, Timo Vesikari, Daisuke Watanabe, Toufik Zahaf, Anitta Ahonen, Eugene Athan, Jose F. Barba-Gomez, Laura Campora, Ferdinandus de Looze, H. Jackson Downey, Wayne Ghesquiere, Iris Gorfinkel, Tiina Korhonen, Edward Leung, Shelly A. McNeil, Lidia Oostvogels, Lars Rombo, Jan Smetana, Lily Weckx, Wilfred Yeo & Thomas C. Heineman. (2016) Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. New England Journal of Medicine 375:11, pages 1019-1032.
Crossref
Crossref
Alyson J. Smith, Yufeng Li, Hélène G. Bazin, Julien R. St-Jean, Daniel Larocque, Jay T. Evans & Jory R. Baldridge. (2016) Evaluation of novel synthetic TLR7/8 agonists as vaccine adjuvants. Vaccine 34:36, pages 4304-4312.
Crossref
Crossref
Geert Leroux-Roels, Arnaud Marchant, Jack Levy, Pierre Van Damme, Tino F. Schwarz, Yves Horsmans, Wolfgang Jilg, Peter G. Kremsner, Edwige Haelterman, Frédéric Clément, Julian J. Gabor, Meral Esen, Annick Hens, Isabelle Carletti, Laurence Fissette, Fernanda Tavares Da Silva, Wivine Burny, Michel Janssens, Philippe Moris, Arnaud M. Didierlaurent, Robbert Van Der Most, Nathalie Garçon, Pascale Van Belle & Marcelle Van Mechelen. (2016) Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial. Clinical Immunology 169, pages 16-27.
Crossref
Crossref
Burcu Temizoz, Etsushi Kuroda & Ken J. Ishii. (2016) Vaccine adjuvants as potential cancer immunotherapeutics. International Immunology 28:7, pages 329-338.
Crossref
Crossref
Hwee-Ing Ng, Germain J. P. Fernando, Alexandra C. I. Depelsenaire & Mark A. F. Kendall. (2016) Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing. Scientific Reports 6:1.
Crossref
Crossref
Else Marie Agger. (2016) Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates. Advanced Drug Delivery Reviews 102, pages 73-82.
Crossref
Crossref
Ângela Rego, Sofia D. Viana, Carlos A. Fontes Ribeiro, Paulo Rodrigues-Santos & Frederico C. Pereira. (2016) Monophosphoryl Lipid-A: A Promising Tool for Alzheimer’s Disease Toll. Journal of Alzheimer's Disease 52:4, pages 1189-1202.
Crossref
Crossref
Jinyu Li, Jinyao Li, Adila Aipire, JiaoJiao Luo, Pengfei Yuan & Fuchun Zhang. (2016) The combination of Pleurotus ferulae water extract and CpG-ODN enhances the immune responses and antitumor efficacy of HPV peptides pulsed dendritic cell-based vaccine. Vaccine 34:31, pages 3568-3575.
Crossref
Crossref
Geert Leroux-Roels, Pierre Van Damme, Wouter Haazen, Sepehr Shakib, Magalie Caubet, Emmanuel Aris, Jeanne-Marie Devaster & Mathieu Peeters. (2016) Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults. Vaccine 34:27, pages 3156-3163.
Crossref
Crossref
Frank Liang & Karin Loré. (2016) Local innate immune responses in the vaccine adjuvant-injected muscle. Clinical & Translational Immunology 5:4, pages e74.
Crossref
Crossref
SHIRIN ELHAIK GOLDMAN, SHAHAR DOTAN, AMIR TALIAS, AMIT LILO, SHALHEVET AZRIEL, ITAY MALKA, MAXIM PORTNOI, ARIEL OHAYON, DANIEL KAFKA, RONALD ELLIS, MOSHE ELKABETS, ANGEL PORGADOR, DITZA LEVIN, ROSA AZHARI, EDWIN SWIATLO, EDUARD LING, GALIA FELDMAN, MICHAEL TAL, RON DAGAN & YAFFA MIZRACHI NEBENZAHL. (2016) Streptococcus pneumoniae fructose-1, 6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice. International Journal of Molecular Medicine 37:4, pages 1127-1138.
Crossref
Crossref
M. Dubničková, E. A. Kuzmina, V. N. Chausov, I. Ravnachka, A. V. Boreyko & E. A. Krasavin. (2016) The effects of lipid A on gamma-irradiated human peripheral blood lymphocytes in vitro. Physics of Particles and Nuclei Letters 13:2, pages 274-278.
Crossref
Crossref
Jorgen Stassijns, Kaatje Bollaerts, Marc Baay & Thomas Verstraeten. (2016) A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children. Vaccine 34:6, pages 714-722.
Crossref
Crossref
Hardeep S. Oberoi, Yvonne M. Yorgensen, Audrey Morasse, Jay T. Evans & David J. Burkhart. (2016) PEG modified liposomes containing CRX-601 adjuvant in combination with methylglycol chitosan enhance the murine sublingual immune response to influenza vaccination. Journal of Controlled Release 223, pages 64-74.
Crossref
Crossref
Annelies Aerssens & Geert Leroux-Roels. (2016) Adjuvanted herpes zoster subunit vaccine. Future Virology 11:1, pages 5-18.
Crossref
Crossref
Nagalingeswaran Kumarasamy, Selvamuthu Poongulali, Anne Bollaerts, Philippe Moris, Faith Esther Beulah, Leo Njock Ayuk, Marie-Ange Demoitié, Erik Jongert & Opokua Ofori-Anyinam. (2016) A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults. Medicine 95:3, pages e2459.
Crossref
Crossref
Robyn Marty-Roix, Gregory I. Vladimer, Kimberly Pouliot, Dan Weng, Rachel Buglione-Corbett, Kim West, John D. MacMicking, Jonathan D. Chee, Shixia Wang, Shan Lu & Egil Lien. (2016) Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants. Journal of Biological Chemistry 291:3, pages 1123-1136.
Crossref
Crossref
S.A. Gray, R.N. Coler, D. Carter & A.A. Siddiqui. 2016. Host-Microbe Interactions. Host-Microbe Interactions
291
315
.
Fred Zepp. 2016. Vaccine Design. Vaccine Design
57
84
.
Jean-Louis Excler, Merlin L. Robb & Jerome H. Kim. (2015) Prospects for a Globally Effective HIV-1 Vaccine. American Journal of Preventive Medicine 49:6, pages S307-S318.
Crossref
Crossref
Jean-Louis Excler, Merlin L. Robb & Jerome H. Kim. (2015) Prospects for a globally effective HIV-1 vaccine. Vaccine 33, pages D4-D12.
Crossref
Crossref
S. Schülke, A. Flaczyk, L. Vogel, N. Gaudenzio, I. Angers, B. Löschner, S. Wolfheimer, I. Spreitzer, S. Qureshi, M. Tsai, S. Galli, S. Vieths & S. Scheurer. (2015) MPLA shows attenuated pro-inflammatory properties and diminished capacity to activate mast cells in comparison with LPS. Allergy 70:10, pages 1259-1268.
Crossref
Crossref
Lawrence Segal, Virginie Roger, Colin Williams, Eric Destexhe & Nathalie Garçon. (2015) Effects of Adjuvant Systems on the cardiovascular and respiratory functions in telemetered conscious dogs and anaesthetised rats. Regulatory Toxicology and Pharmacology 73:1, pages 116-125.
Crossref
Crossref
Zoltan Beck, Gary R. Matyas, Rashmi Jalah, Mangala Rao, Victoria R. Polonis & Carl R. Alving. (2015) Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21. Vaccine 33:42, pages 5578-5587.
Crossref
Crossref
José L. Tlaxca, Scott Ellis & Richard L. RemmeleJr.Jr.. (2015) Live attenuated and inactivated viral vaccine formulation and nasal delivery: Potential and challenges. Advanced Drug Delivery Reviews 93, pages 56-78.
Crossref
Crossref
Thorunn Olafsdottir, Madelene Lindqvist & Ali M. Harandi. (2015) Molecular signatures of vaccine adjuvants. Vaccine 33:40, pages 5302-5307.
Crossref
Crossref
Adam Penn-Nicholson, Hennie Geldenhuys, Wivine Burny, Robbert van der Most, Cheryl L. Day, Erik Jongert, Philippe Moris, Mark Hatherill, Opokua Ofori-Anyinam, Willem Hanekom, Anne Bollaerts, Marie-Ange Demoitie, Angelique Kany Kany Luabeya, Evi De Ruymaeker, Michele Tameris, Didier Lapierre & Thomas J. Scriba. (2015) Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting. Vaccine 33:32, pages 4025-4034.
Crossref
Crossref
Melissa C. Hanson, Monica P. Crespo, Wuhbet Abraham, Kelly D. Moynihan, Gregory L. Szeto, Stephanie H. Chen, Mariane B. Melo, Stefanie Mueller & Darrell J. Irvine. (2015) Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants. Journal of Clinical Investigation 125:6, pages 2532-2546.
Crossref
Crossref
Himal Lal, Anthony L. Cunningham, Olivier Godeaux, Roman Chlibek, Javier Diez-Domingo, Shinn-Jang Hwang, Myron J. Levin, Janet E. McElhaney, Airi Poder, Joan Puig-Barberà, Timo Vesikari, Daisuke Watanabe, Lily Weckx, Toufik Zahaf & Thomas C. Heineman. (2015) Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. New England Journal of Medicine 372:22, pages 2087-2096.
Crossref
Crossref
Jeffrey I. Cohen. (2015) A New Vaccine to Prevent Herpes Zoster. New England Journal of Medicine 372:22, pages 2149-2150.
Crossref
Crossref
Clarisse Lorin, Yannick Vanloubbeeck, Sébastien Baudart, Michaël Ska, Babak Bayat, Geoffroy Brauers, Géraldine Clarinval, Marie-Noëlle Donner, Martine Marchand, Marguerite Koutsoukos, Pascal Mettens, Joe Cohen & Gerald Voss. (2015) Heterologous Prime-Boost Regimens with a Recombinant Chimpanzee Adenoviral Vector and Adjuvanted F4 Protein Elicit Polyfunctional HIV-1-Specific T-Cell Responses in Macaques. PLOS ONE 10:4, pages e0122835.
Crossref
Crossref
Stefan Fernandez, Stephen J. Thomas, Rafael De La Barrera, Rawiwan Im-erbsin, Richard G. Jarman, Benoît Baras, Jean-François Toussaint, Sally Mossman, Bruce L. Innis, Alexander Schmidt, Marie-Pierre Malice, Pascale Festraets, Lucile Warter, J. Robert Putnak & Kenneth H. Eckels. (2015) An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques. The American Journal of Tropical Medicine and Hygiene 92:4, pages 698-708.
Crossref
Crossref
Supatsak Subharat, Dairu Shu, Tao Zheng, Bryce M. Buddle, Peter H. Janssen, Dongwen Luo & D. Neil Wedlock. (2015) Vaccination of cattle with a methanogen protein produces specific antibodies in the saliva which are stable in the rumen. Veterinary Immunology and Immunopathology 164:3-4, pages 201-207.
Crossref
Crossref
Charlotte N Maughan, Stephen G Preston & Gareth R Williams. (2015) Particulate inorganic adjuvants: recent developments and future outlook. Journal of Pharmacy and Pharmacology 67:3, pages 426-449.
Crossref
Crossref
Zoltan Beck, Gary R. Matyas & Carl R. Alving. (2015) Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate. Biochimica et Biophysica Acta (BBA) - Biomembranes 1848:3, pages 775-780.
Crossref
Crossref
Geert Leroux-Roels, Pascale Van Belle, Pierre Vandepapeliere, Yves Horsmans, Michel Janssens, Isabelle Carletti, Nathalie Garçon, Martine Wettendorff & Marcelle Van Mechelen. (2015) Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination. Vaccine 33:8, pages 1084-1091.
Crossref
Crossref
Geert Leroux-Roels. (2014) Old and new adjuvants for hepatitis B vaccines. Medical Microbiology and Immunology 204:1, pages 69-78.
Crossref
Crossref
Isabel Leroux-Roels, Jeanne-Marie Devaster, Geert Leroux-Roels, Vincent Verlant, Isabelle Henckaerts, Philippe Moris, Philippe Hermand, Pascale Van Belle, Jan T. Poolman, Pierre Vandepapelière & Yves Horsmans. (2015) Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: Randomised, controlled trials. Vaccine 33:4, pages 577-584.
Crossref
Crossref
Stela Maris Kuze Rates, Andresa Heemann Betti, Liz Girardi Müller & Jéssica de Matos Nunes. 2015. Plant Toxins. Plant Toxins
1
21
.
Anna KabanovaLaurent PerezDaniele Lilleri, Jessica MarcandalliGloria Agatic, Simone BecattiniSilvia PreiteDario FuschilloElena PercivalleFederica SallustoGiuseppe Gerna, Davide Corti & Antonio Lanzavecchia. (2014) Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies. Proceedings of the National Academy of Sciences 111:50, pages 17965-17970.
Crossref
Crossref
Olubukola T. Idoko, Olumuyiwa A. Owolabi, Patrick K. Owiafe, Philippe Moris, Aderonke Odutola, Anne Bollaerts, Ezra Ogundare, Erik Jongert, Marie-Ange Demoitié, Opokua Ofori-Anyinam & Martin O. Ota. (2014) Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: An open-label randomized controlled trial. Tuberculosis 94:6, pages 564-578.
Crossref
Crossref
Jianchun Wei, Hui Chen & Jing An. (2014) Recent progress in dengue vaccine development. Virologica Sinica 29:6, pages 353-363.
Crossref
Crossref
Edward A. StadtmauerKeith M. SullivanFrancisco M. MartySanjeet S. DadwalGenovefa A. PapanicolaouThomas C. SheaSherif B. MossadCharalambos AndreadisJo-Anne H. YoungFrancis K. BuadiMohamed El Idrissi, Thomas C. Heineman & Elchonon M. Berkowitz. (2014) A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. Blood 124:19, pages 2921-2929.
Crossref
Crossref
Reto A. Schwendener. (2014) Liposomes as vaccine delivery systems: a review of the recent advances. Therapeutic Advances in Vaccines 2:6, pages 159-182.
Crossref
Crossref
Laure Ysebrant de Lendonck, Valerie Martinet & Stanislas Goriely. (2014) Interferon regulatory factor 3 in adaptive immune responses. Cellular and Molecular Life Sciences 71:20, pages 3873-3883.
Crossref
Crossref
Mira C Patel, Kari Ann Shirey, Lioubov M Pletneva, Marina S Boukhvalova, Alfredo Garzino-Demo, Stefanie N Vogel & Jorge CG Blanco. (2014) Novel drugs targeting Toll-like receptors for antiviral therapy. Future Virology 9:9, pages 811-829.
Crossref
Crossref
Malcolm S. Duthie & Steven G. Reed. (2014) The Emergence of Defined Subunit Vaccines for the Prevention of Leishmaniasis. Current Tropical Medicine Reports 1:3, pages 154-162.
Crossref
Crossref
Arnaud M. Didierlaurent, Catherine Collignon, Patricia Bourguignon, Sandrine Wouters, Kaat Fierens, Michel Fochesato, Najoua Dendouga, Christelle Langlet, Bernard Malissen, Bart N. Lambrecht, Nathalie Garçon, Marcelle Van Mechelen & Sandra Morel. (2014) Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells. The Journal of Immunology 193:4, pages 1920-1930.
Crossref
Crossref
Jean-Louis Excler, Julie Ake, Merlin L. Robb, Jerome H. Kim & Stanley A. Plotkin. (2014) Nonneutralizing Functional Antibodies: a New “Old” Paradigm for HIV Vaccines. Clinical and Vaccine Immunology 21:8, pages 1023-1036.
Crossref
Crossref
Displaying 200 of 251 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list